1-Butylimidazole

Hazard statements (CLP)

H315, H318, H335

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger Danger

Hazard statements

H315 Causes skin irritation. H318 Causes serious eye damage. H335 May cause respiratory irritation. H318 Causes serious eye damage.

Precautionary statements

P261 Avoid breathing dust / fume / gas / mist / vapours / spray. P264 Wash skin thoroughly after handling. P271 Use only outdoors or in well-ventilated area. P280 Wear protective gloves/protective clothing/eye protection/face protection. P302 + P352 IF ON SKIN: Wash with soap and water. P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338 IF IN EYES: Rinse continuously with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER or doctor/physician. P332 + P313 If skin irritation occurs: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse. P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up. Reduced labelling for bottles < 125 mL (according to Art. 29.2) P280 Wear protective gloves/protective clothing/eye protection/face protection. P305 + P351 + P338 IF IN EYES: Rinse continuously with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER or doctor/physician.

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Classification (REGULTATION (EC) No 1272/2008) Skin Irritation (Category 2) Eye Damage (Category 1) Specific target organ toxicity – Single exposure (Category 3)